Chapter title |
Degradomics in Neurotrauma: Profiling Traumatic Brain Injury
|
---|---|
Chapter number | 4 |
Book title |
Neuroproteomics
|
Published in |
Methods in molecular biology, January 2017
|
DOI | 10.1007/978-1-4939-6952-4_4 |
Pubmed ID | |
Book ISBNs |
978-1-4939-6950-0, 978-1-4939-6952-4, 978-1-4939-6950-0, 978-1-4939-6952-4
|
Authors |
Hadi Abou-El-Hassan, Fares Sukhon, Edwyn Jeremy Assaf, Hisham Bahmad, Hussein Abou-Abbass, Hussam Jourdi, Firas H. Kobeissy |
Editors |
Firas H. Kobeissy, Stanley M. Stevens, Jr. |
Abstract |
Degradomics has recently emerged as a subdiscipline in the omics era with a focus on characterizing signature breakdown products implicated in various disease processes. Driven by promising experimental findings in cancer, neuroscience, and metabolomic disorders, degradomics has significantly promoted the notion of disease-specific "degradome." A degradome arises from the activation of several proteases that target specific substrates and generate signature protein fragments. Several proteases such as calpains, caspases, cathepsins, and matrix metalloproteinases (MMPs) are involved in the pathogenesis of numerous diseases that disturb the physiologic balance between protein synthesis and protein degradation. While regulated proteolytic activities are needed for development, growth, and regeneration, uncontrolled proteolysis initiated under pathological conditions ultimately culminates into apoptotic and necrotic processes. In this chapter, we aim to review the protease-substrate repertoires in neural injury concentrating on traumatic brain injury. A striking diversity of protease substrates, essential for neuronal and brain structural and functional integrity, namely, encryptic biomarker neoproteins, have been characterized in brain injury. These include cytoskeletal proteins, transcription factors, cell cycle regulatory proteins, synaptic proteins, and cell junction proteins. As these substrates are subject to proteolytic fragmentation, they are ceaselessly exposed to activated proteases. Characterization of these molecules allows for a surge of "possible" therapeutic approaches of intervention at various levels of the proteolytic cascade. |
X Demographics
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 17 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 2 | 12% |
Other | 2 | 12% |
Student > Ph. D. Student | 2 | 12% |
Lecturer > Senior Lecturer | 1 | 6% |
Lecturer | 1 | 6% |
Other | 4 | 24% |
Unknown | 5 | 29% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 4 | 24% |
Medicine and Dentistry | 3 | 18% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 6% |
Chemical Engineering | 1 | 6% |
Computer Science | 1 | 6% |
Other | 1 | 6% |
Unknown | 6 | 35% |